Research and Markets: Colorectal Cancer (Event Driven)

DUBLIN--(BUSINESS WIRE)-- Research and Markets ( has announced the addition of Decision Resources, Inc's new report "Colorectal Cancer (Event Driven)" to their offering.

Colorectal cancer (CRC) is one of the most common forms of cancer and in 2010 was the fifth most common cancer-related death worldwide. Over the next ten years the number of incident cases of CRC will increase as the aging population continues to expand and patients continue to be identified through screening efforts throughout the major markets. Although in 2010 major-market sales of CRC treatments totaled more than $7 billion, reflecting robust sales of premium-priced products, interviewed experts express the demand for more treatments that address CRC patients' numerous unmet needs.

Key Topics Covered:

Executive Summary

What are the key parameters of the colorectal cancer market?

What factors are driving the market for colorectal cancer therapies?

What factors are constraining the market for colorectal therapies?

What are the drug development activities of note in colorectal cancer?

What do the experts say?

What key challenges and opportunities remain?

1 Etiology and Pathophysiology

2 Epidemiology and Patient Populations

3 Current Therapy and Medical Practice

4 Unmet Needs

5 Emerging Therapies

6 Market Outlook


Tables and Figures

For more information visit

Source: Decision Resources, Inc

Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices, Oncology, Colon Cancer

Source: Research and Markets